Message Font: Serif | Sans-Serif
No. of Recommendations: 0
From the research that I have access to, this deal if it happens, should expand earnings forecasts because it was recognized as a possibility, but not factored into most forecasts.

This should bode well for price appreciation through positive earnings surprises and possible PE multiple expansion as DOSE becomes the recognized industry leader in the institutional pharmacy industry.

Barring unforseen events, $20 to $24 per share over the next 12 months is very feasable.
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.